Dr Weikert has more than 10 years of experience in the pharmaceutical industry. Prior to founding Inventages, Dr Weikert was a senior vice president and global head for life science deals at Bayer AG. While at Bayer, he oversaw venture investments in technology companies and collaborations representing some of the most significant deals between big-pharma and biotechnology at that time.

Dr. Weikert received his MD from the University of Düsseldorf and his PhD in the field of metabolism from the Diabetes Research Center in Germany. He also holds an MBA.

Mr. Pedersen’s responsibilities included the establishment of Lundbeck in the USA and Japan. Mr Pedersen was with Lundbeck for over 20 years serving in various positions within business development, corporate affairs and commercialization. Mr Pedersen serves as the Executive Chairman of the Board of moksha8; Chairman of the Boards of  x3Capital A/S and Ergolet A/S and Board member of Index Pharmaceuticals AB and Broen-Lab A/S. Mr. Pedersen obtained a Bachelor of Economics degree in 1983 and a Master of Science degree in Economics in 1985, both from the University of Aalborg.

Mr Guld co-founded Zadall Systems Group and grew it into one of the leading prescription processing companies in North America, processing over a billion prescriptions per year before selling to what is now McKesson. In 2001 Mr Guld joined Ventures West, the largest Venture Capital Company in Canada. Mr Guld has founded, invested or had significant interest in several IT and Healthcare technology companies in Canada and the United States. Mr Guld serves on the boards of One Carbon Therapeutics, Shoes.com, SecureRF and the Mark Anthony Group of companies.